Need for a model that thinks much harder about the impact on patients, says RCA CEO

Pharma News: For too long, ‘patient-centricity’ and ‘person centred care’ have merely been notional concepts that have not been reflected in the reality of patients’ lived experience.

Chief Executive of Rare Cancers Australia (RCA), Richard Vines, joined Health Industry Hub to deep dive into the recently released report The Rights and Roles of Australian Cancer Patients that aims to better understand the scale of the challenge we face in delivering the best person-centred care for Australian cancer patients.

With input from more than one thousand patients and carers, along with patient advocates, clinicians, and representatives from the pharmaceutical industry and patient organisations, this report explored how patients can be at the centre of their own care and have roles to inform healthcare decision making at the broader systems level. This will ensure that ‘patient-centricity’ or ‘person-centred-care’ is not just a catch phrase but a lived reality.

Richard also reflected on the upcoming independent review of the Health Technology Assessment (HTA) and the opportunity for a “model that thinks much harder about the impact on patients.”